Tonix Pharmaceuticals Holding (TNXP) EBITDA Margin Growth (3y) (2025)

Tonix Pharmaceuticals Holding (TNXP) EBITDA Margin Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Oculis Holding AG 66,981.90 Bn 66,981.62 Bn - -
2 Nanobiotix 1,913.50 Bn 1,913.44 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 472.03 Bn 467.24 Bn 1.35 Bn 9,942.00
5 Vertex Pharmaceuticals 122.09 Bn 114.84 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 70.01 Bn 61.26 Bn 3.31 Bn -1,211.00
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.99 Bn 50.80 Bn 1.41 Bn -623.00
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn 6,993.00
10 Tonix Pharmaceuticals Holding 141.73 Mn 141.73 Mn 5.30 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -19,102.00
Jun 30, 2025 -92,338.00